Salaries and Expenses
Schedules
TAFS: 075-0600 /X - Salaries and Expenses
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1000 | DE1 | Discretionary Estimated - Unob Bal: Brought forward, Oct 1 | $1,823,436,942.00 | See footnotes below |
| Footnotes for line 1000 (DE1): | B1: This amount reflects the net of anticipated advance collections in FY 2021 for FY 2022 that would be available under a continuing resolution or enactment of an appropriations for FDA (see Sheet 2). B2: This amount reflects the net of unappropriated excess collections precluded from obligation for ADUFA ($2,058,256), AGDUFA ($2,363,711), and MDUFA ($39,912,561). | |||
| 1000 | ME1 | Mandatory Estimated - Unob Bal: Brought forward, Oct 1 | $1,255,769.00 | |
| 1061 | Unob Bal: Antic recov of prior year unpd/pd obl | $84,970,000.00 | ||
| 1724 | BA: Disc: Spending auth: Precluded from ob (lim) | -$79,468,729.00 | See footnotes below | |
| Footnotes for line 1724: | B3: The total on line 1724 represents a net of an increase in FY 2022 of $617,834 for MDUFA (a new total of $40,530,395 which includes $20,240,978 in unappropriated excess collections and $20,289,417 for the 1-month reserve) and $78,850,895 for PDUFA unappropriated excess collections. | |||
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $175,201,525.00 | ||
| 1802 | BA: Mand: Spending auth: Previously unavailable | $28,500.00 | ||
| 1823 | SEQ | BA: Mand: Spending auth: New\Unob bal temp reduced | -$28,500.00 | |
| 1840 | BA: Mand: Spending auth:Antic colls, reimbs, other | $500,000.00 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $2,005,895,507.00 | ||
| 6011 | PDUFA | $353,613,886.00 | ||
| 6012 | MDUFA | $328,867,909.00 | ||
| 6013 | ADUFA | $25,013,876.00 | ||
| 6014 | AGDUFA | $27,552,935.00 | ||
| 6015 | TOBACCO | $404,162,150.00 | ||
| 6016 | MQSA | $17,242,771.00 | ||
| 6017 | EREA | $12,203,923.00 | ||
| 6018 | CONTINGENCY FUND | $352,571.00 | ||
| 6019 | COUNTER-TERRORISM | $843,878.00 | ||
| 6020 | Oil Spill | $41.00 | ||
| 6021 | Priority Voucher Review | $7,378,700.00 | ||
| 6022 | GDUFA | $184,338,949.00 | ||
| 6023 | BSUFA | $44,994,087.00 | ||
| 6026 | Food & Drug Safety | $745,172.00 | ||
| 6027 | FOIA | $1,837,157.00 | ||
| 6028 | EBOLA | $63,403.00 | ||
| 6029 | PRV-Pediatric Disease | $17,914,696.00 | ||
| 6030 | Outsourcing Facility | $470,528.00 | ||
| 6031 | Energy Saving Rebates | $199,435.00 | ||
| 6033 | Food Inspection | $6,673,000.00 | ||
| 6034 | Food Recall | $1,492,000.00 | ||
| 6035 | Zika Activities | $131,264.00 | ||
| 6036 | Third Party Auditors | $729,236.00 | ||
| 6037 | MCMi | $56,322.00 | ||
| 6038 | VQIP | $5,531,681.00 | ||
| 6039 | Reimbursements | $8,084,000.00 | ||
| 6040 | Opioids-IMF | $7,685,774.00 | ||
| 6042 | Coronavirus Emergency Funding (P.L. 116-123) | $5,356,893.00 | See footnotes below | |
| Footnotes for line 6042: | A5: HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-123. | |||
| 6043 | Coronavirus Response (P.L. 116-136) | $48,940,843.00 | See footnotes below | |
| Footnotes for line 6043: | A6: HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-136. | |||
| 6044 | Over the Counter Monograph | $46,283,502.00 | ||
| 6045 | Coronavirus Response (P.L.116-139) | $17,685,662.00 | See footnotes below | |
| Footnotes for line 6045: | A7: HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-139. | |||
| 6046 | Coronavirus Relief Funding (P.L. 116-260) | $33,623,451.00 | See footnotes below | |
| Footnotes for line 6046: | A8: HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-260. | |||
| 6047 | Seafood Safety Studies-GP Sec. 765 | $100,000.00 | ||
| 6048 | Coronavirus ARP Act (P.L. 117-002) | $395,725,812.00 | See footnotes below | |
| Footnotes for line 6048: | A9: Funds are available for obligation five business days after an HHS approved spend plan has been submitted to OMB. | |||
| 6190 | Total budgetary resources available | $2,005,895,507.00 | See footnotes below | |
| Footnotes for line 6190: | A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. A2: Pursuant to 31 USC 1553(b), not to exceed 1 percent of total appropriation for this account is apportioned for the purpose of paying legitimate obligations related to cancelled appropriations. A3: The total amount apportioned may be increased for additional spending authority from offsetting collections received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. A4: Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments. | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. |
| A2 | Pursuant to 31 USC 1553(b), not to exceed 1 percent of total appropriation for this account is apportioned for the purpose of paying legitimate obligations related to cancelled appropriations. |
| A3 | The total amount apportioned may be increased for additional spending authority from offsetting collections received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| A4 | Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments. |
| A5 | HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-123. |
| A6 | HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-136. |
| A7 | HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-139. |
| A8 | HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-260. |
| A9 | Funds are available for obligation five business days after an HHS approved spend plan has been submitted to OMB. |
| B1 | This amount reflects the net of anticipated advance collections in FY 2021 for FY 2022 that would be available under a continuing resolution or enactment of an appropriations for FDA (see Sheet 2). |
| B2 | This amount reflects the net of unappropriated excess collections precluded from obligation for ADUFA ($2,058,256), AGDUFA ($2,363,711), and MDUFA ($39,912,561). |
| B3 | The total on line 1724 represents a net of an increase in FY 2022 of $617,834 for MDUFA (a new total of $40,530,395 which includes $20,240,978 in unappropriated excess collections and $20,289,417 for the 1-month reserve) and $78,850,895 for PDUFA unappropriated excess collections. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.